FeesSafety
Pluang+

Strategy buys 1,036 bitcoin for $82M, raising total holdings to 850,364 BTC at $75,456 avg price.

09 Nov 2026, 15:05 WIB
Crypto Briefing
View Source
Bullish
Strategy buys 1,036 bitcoin for $82M, raising total holdings to 850,364 BTC at $75,456 avg price.

Strategy purchased 1,036 bitcoin for about $82 million during the week of November 2-8, 2026, at an average price of $79,012 per bitcoin, funded entirely by selling its common stock. This brings its total bitcoin holdings to 850,364 coins, acquired at an average cost of $75,456 each. The company also repurchased $188.3 million of preferred shares and maintains significant capacity to raise more capital through stock issuance programs. It holds $4.77 billion in USD reserves to support preferred dividends and $146.2 million in cash for bitcoin purchases and other uses.

Strategy's recent bitcoin purchase and preferred share repurchase provide context for readers following cryptocurrency markets. For readers following cryptocurrencies, here is Pluang's market snapshot as of Nov 09, 2026 20:02 WIB: out of 50 major cryptocurrencies tradable on Pluang, 17 rose and 32 fell today. Notable price changes include BAL (Balancer) at Rp16.297 with a 1-day change of +11.14%, EOS (EOS.IO) at Rp12.649 with +8.13%, and ZIL (Zilliqa) at Rp32 with +6.64%, where ZIL's Pluang order activity was 74% Sell and 26% Buy.

More News

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...

Market News
Neutral
1 hour ago
New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...

Company Fundamentals
Bullish
2 hours ago
Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...

Bearish
2 hours ago
Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...

Market News
Bullish
2 hours ago
ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App